Position in BNTX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,444,033
-$4,859,726 QoQ
Shares Held
16,247
-79.3% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,537,836 across 424 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in BNTX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,444,033 | 16,247 | Shares | Defined | 2026-05-14 | |
| 2024-06-30 | $6,303,759 | 78,444 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $7,493,651 | 81,232 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $8,601,193 | 81,497 | Shares | Defined | 2024-02-13 | |
| 2021-12-31 | $5,766,984 | 22,370 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $11,836,844 | 43,360 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||